Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

Mumbai: Sanofi India and Cipla announced on Tuesday an exclusive partnership to boost access to Sanofi’s Central Nervous System (CNS) medications across India.

Cipla will leverage its extensive network to distribute Sanofi’s CNS portfolio, including Frisium, a leading anti-epileptic drug. Sanofi will retain ownership, import, and manufacture of the CNS products.

Commenting on this, Rodolfo Hrosz, Managing Director of Sanofi India, stated, “Sanofi India’s CNS products are leaders in their respective categories. These well-established brands already improve the lives of many patients across urban centres in the country. Cipla’s wide presence will enable us to expand the reach of this portfolio to healthcare professionals and patients across all India.”

Speaking on this, Achin Gupta, Chief Executive Officer of Cipla’s One India Business, stated, “We are pleased to collaborate with Sanofi India to enhance accessibility to highly efficacious and quality therapeutic solutions in CNS and bring value to patients across the country. The Central Nervous System is one of the most challenging areas in medicine, and we believe this partnership is a significant step forward to address unmet needs of patients.”

Related Posts

  • Pharma
  • June 13, 2025
  • 58 views
DCA raids medical shop in Hyderabad, illegal medicines worth Rs 25K seized

Officials found New Al-Shifa Medical and General Stores located at Zamistanpur in Musheerabad was running without a proper drug licence. Hyderabad: A medical shop in Hyderabad was raided by officials…

  • Pharma
  • June 13, 2025
  • 71 views
Pharma firm Captab Biotech banned in Punjab for 3 years following adverse drug reactions

Chandigarh, The Punjab government has banned pharma company Captab Biotech for three years for manufacturing and supplying non-standard IV fluid or normal saline bottles to the Punjab Health System Corporation…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DCA raids medical shop in Hyderabad, illegal medicines worth Rs 25K seized

DCA raids medical shop in Hyderabad, illegal medicines worth Rs 25K seized

Pharma firm Captab Biotech banned in Punjab for 3 years following adverse drug reactions

Pharma firm Captab Biotech banned in Punjab for 3 years following adverse drug reactions

FUJIFILM resolves to detect Breast Cancer early with Apollo Hospitals

FUJIFILM resolves to detect Breast Cancer early with Apollo Hospitals

Dabur reaches out to distributors as quick commerce disrupts general trade

Dabur reaches out to distributors as quick commerce disrupts general trade